Company Profile | ![]() | 0-9 | ![]() | A | ![]() | B | ![]() | C | ![]() | D | ![]() | E | ![]() | F | ![]() | G | ![]() | H | ![]() | I | ![]() | J | ![]() | K | ![]() | L | ![]() | M | ![]() | N | ![]() | O | ![]() | P | ![]() | Q | ![]() | R | ![]() | S | ![]() | T | ![]() | U | ![]() | V | ![]() | W | ![]() | X | ![]() | Y | ![]() | Z |
Takeda Pharmaceutical Co. Ltd.
(NYSE: TAK)
|
7:50 PM UTC, 04/14/25 | |||
---|---|---|---|---|
Last: $14.34 | Change: +0.46 | %Change: +3.28% | Volume: 1,589,622 |
Period | Eps Estimate |
Eps Actual |
Prev-Year Actual |
Date/Time (ET) |
---|---|---|---|---|
Q3 2024 | 0.09 | 0.05 | 0.23 | 31-Dec-24 |
Q2 2024 | 0.12 | 0.19 | -0.10 | 30-Sep-24 |
Q1 2024 | 0.12 | 0.20 | 0.20 | 30-Jun-24 |
Q4 2024 | 0.00 | -0.01 | 0.07 | 31-Mar-24 |
Period | Eps Estimate |
Eps Actual |
Prev-Year Actual |
Date/Time (ET) |
---|---|---|---|---|
Q4 2025 | -0.18 | n.a. | -0.01 | 31-Mar-25 |